Coronavirus disease 2019 (COVID-19) has provoked a catastrophic medical emergency worldwide [1]. In the course of time from the beginning of this pandemic, subacute and long-term effects in patients suffering from COVID-19 have been increasingly recognised [1,2]. Thus, the term “long-COVID-19” has been proposed to describe this collection of signs and symptoms which may continue or sometimes develop following the SARS-CoV-2 infection. The latter is defined as post-COVID-19 syndrome [3].
Ruscitti, P., Ursini, F., Shoenfeld, Y. (2023). Ferritin and myalgic encephalomyelitis/chronic fatigue syndrome in post COVID-19, an unexpected facet of the hyperferritinemic syndrome?. JOURNAL OF PSYCHOSOMATIC RESEARCH, -, 1-3 [10.1016/j.jpsychores.2023.111231].
Ferritin and myalgic encephalomyelitis/chronic fatigue syndrome in post COVID-19, an unexpected facet of the hyperferritinemic syndrome?
Ursini, Francesco;
2023
Abstract
Coronavirus disease 2019 (COVID-19) has provoked a catastrophic medical emergency worldwide [1]. In the course of time from the beginning of this pandemic, subacute and long-term effects in patients suffering from COVID-19 have been increasingly recognised [1,2]. Thus, the term “long-COVID-19” has been proposed to describe this collection of signs and symptoms which may continue or sometimes develop following the SARS-CoV-2 infection. The latter is defined as post-COVID-19 syndrome [3].I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
